Kairos Pharma to sell 1.55 million shares in IPO at $4 each

"Tiger gets early look at Valhalla for PGA Champ." - Read more, ESPN GOLF: May 09, 2024 |
"Wyndham Clark looks to defend his title and Nelly Korda tries to continue her win…" - Read more, ESPN GOLF: May 09, 2024 |
"Jerry Seinfeld Says Howard Stern Lacks Comedic Chops, Podcasters Passed Him" - Read more, TMZ: May 08, 2024 |
"Steve Urkel Actor Jaleel White Marries Tech Exec in Country Club Wedding" - Read more, TMZ: May 08, 2024 |
"Director Sam Raimi's Wife of 31 Years Files for Divorce" - Read more, TMZ: May 08, 2024 |
"The House Boos Marjorie Taylor Greene As She Initiates Motion To Vacate" - Read more, PoliticusUSA: May 08, 2024 |
"Christine Quinn's Husband Charged with Child Abuse, Assault Misdemeanors" - Read more, TMZ: May 08, 2024 |
"Busy Korda: 'Not thought' about pursuit of record" - Read more, ESPN GOLF: May 08, 2024 |
"Farrah Abraham Seems to Shade Jenelle Evans 'Teen Mom' Return" - Read more, TMZ: May 08, 2024 |
"Shohei Ohtani's Interpreter Pleading Guilty To Federal Charges, Facing Up To 33 Yrs" - Read more, TMZ: May 08, 2024 |

Kairos Pharma to sell 1.55 million shares in IPO at $4 each

By: market watch Posted On: February 14, 2024 View: 46

Kairos Pharma plans to sell about 1.55 million shares in its initial public offering at $4 per share.

The Los Angeles-based company said in a regulatory filing on Wednesday it expects net proceeds of $5.6 million, which it plans to use to fund clinical development of its lead product candidates. Proceeds will also be used for paying outstanding accounts payable, working capital and general corporate purposes.

The...

Master your money.

Subscribe to MarketWatch.

Get this article and all of MarketWatch.

Access from any device. Anywhere. Anytime.

Subscribe Now

Already a subscriber? Log In

Adblock test (Why?)

Read this on market watch Header Banner

Contact Us

Contact Form

About

Brainfind is your one-stop shop for breaking news headlines and personalized news stories. Not only are we a news aggregator and content curator, we also allow registered users to publish their own articles on our website with full credit and their social links.